glp-1 ras drugs Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment GLP-1 Agonists: A Comprehensive Overview

Description

Diabetic cardiomyopathy (DCM) refers to the presence of abnormal myocardial structure and performance in the absence of other heart-related risk factors (such as coronary artery-related disease, hypertension, and severe valvular disease)

The risk of cardiovascular disease is thought to be at least double that for people with lupus

Diabetes Obes Metab 22:938946

When the same area receives repeated injections, scar tissue and lipodystrophy can develop beneath the skin surface, invisible to the eye but tangible to the touch

66% of companies with 5,000 or more employees and 43% of companies with 1,000 to 4,999 employees said covering the drugs had a significant effect on their health plans prescription drug spending